Merck posts new late-stage trial win for Keytruda (MRK:NYSE)

Merck posts new late-stage trial win for Keytruda (MRK:NYSE)  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.